13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-091264
Total Value
$709.3M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 2,344,980 | $168.5M | 23.76% |
| 2 | NUVALENT INC | NUVL | 2,884,492 | $121.6M | 17.15% |
| 3 | IMMUNOGEN INC | 45253H101 | 6,029,592 | $113.8M | 16.04% |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 2,124,625 | $43.4M | 6.11% |
| 5 | COGENT BIOSCIENCES INC | COGT | 3,558,975 | $42.1M | 5.94% |
| 6 | MERUS N V | N5749R100 | 1,482,405 | $39.0M | 5.50% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,369,623 | $32.6M | 4.59% |
| 8 | ARGENX SE | ARGX | 73,526 | $28.7M | 4.04% |
| 9 | TYRA BIOSCIENCES INC | TYRA | 1,416,998 | $24.1M | 3.40% |
| 10 | TERNS PHARMACEUTICALS INC | TERN | 2,040,000 | $17.9M | 2.52% |
| 11 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,901,397 | $15.8M | 2.23% |
| 12 | KODIAK SCIENCES INC | KOD | 1,985,245 | $13.7M | 1.93% |
| 13 | DBV TECHNOLOGIES SA | DBVTF | 7,064,964 | $13.4M | 1.89% |
| 14 | TREVI THERAPEUTICS INC | TRVI | 5,190,360 | $12.4M | 1.75% |
| 15 | KINIKSA PHARMACEUTICALS LTD | KNSA | 704,459 | $9.9M | 1.40% |
| 16 | VERONA PHARMA PLC | 925050106 | 381,939 | $8.1M | 1.14% |
| 17 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 9,460,540 | $4.3M | 0.60% |